Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
or
The number of tumor-infiltrating CD3+ and CD25+ cells positively correlates with clinical response to rituximab in follicular lymphoma patients
ÌÇÐÄ´«Ã½
The number of tumor-infiltrating CD3+ and CD25+ cells positively correlates with clinical response to rituximab in follicular lymphoma patients 94th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology Park, C. Y., Bohen, S. P., Levy, R., Warnke, R., Nathunam, Y. NATURE PUBLISHING GROUP. 2005: 245A–245AView details for